|
Home
Live Seminars
About the Program
Quick Order
Hotel Registration
Auto Rental
Accreditation
Cancellation Policy
Testimonials
Video DVDs
MP3s/Audio CDs
Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us
|
|
|
|
by Michael P. Goldfinger, M.D., F.A.C.P. - Jefferson Medical College, Thomas Jefferson University; Assistant Professor of Medicine; Director, Continuous Quality Improvement and Director, Peer/Mortality Review, Department of Medicine, Division of General Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA; by Merri Lou Pendergrass, M.D., Ph.D. - Harvard Medical School; Associate Professor of Medicine; National Practice Leader for Diabetes, Medco Health Solutions, Fort Worth, TX; by Gerald W. Smetana, M.D. - Harvard Medical School; Associate Professor of Medicine; Director of CME, Division of General Medicine and Primary Care, Beth Isr ael Deaconess Medical Center, Boston, MA and by C. Christopher Smith, M.D. - Harvard Medical School; Assistant Professor of Medicine; Associate Director, Internal Medicine Residency Training Program, Associate Firm Chief, Blumgart Medical Firm, and Co-Director, Rabkin Fellowship in Medical Education, Beth Israel Deaconess Medical Center of Harvard Medical School, Boston, MA.
Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website
|
|
Internal Medicine: A Clinical Update
March 16-20, 2009
Location: Hyatt Regency Sarasota, Florida
OBJECTIVES
| OVERALL OBJECTIVES: The overall objective is to provide the participant with practical and clinically relevant information. Upon completion of this CME activity, the physician or healthcare provider should be able to describe the current approach to formulating differential diagnoses, diagnostic, therapeutic, and preventive management of the various disciplines presented. |
| SPECIFIC OBJECTIVES
| | Day 1 | Approach to the Patient with Hypertension. - Upon completion of this session, the participant should be able to:
| 1. | Appreciate that all antihypertensive medications do not equally reduce cardiovascular risk.
| | 2. | Apply the JNC-7 guidelines to clinical care of hypertensive patients.
| | 3. | Recognize compelling indications for selection of initial antihypertensive therapy.
| | 4. | Identify which drugs most effectively reduce the risk of cardiovascular disease.
| | New Drugs for the Primary Care Physician: What You Need to Know. - Upon completion of this session, the participant should be able to:
| | 1. | Survey important advances in pharmacotherapy that pertain to primary care practice.
| | 2. | Discuss the efficacy and list the side effects for each drug.
| | 3. | Compare key new drugs with previously available medications for similar indications.
| | Important Drug Interactions and Side Effects. - Upon completion of this session, the participant should be able to:
| | 1. | Discuss the most common mechanisms for drug interactions.
| | 2. | Identify some of the most frequent culprit drugs.
| | 3. | Counsel patients regarding some of the most frequent side-effects seen with commonly used medications.
| | Approach to the Patient with Syncope. - Upon completion of this session, the participant should be able to:
| | 1. | Discuss the various etiologies of syncope.
| | 2. | Use clues in the history and physical as well as simple office testing to risk-stratify patients.
| | 3. | Develop a plan for appropriate use of additional testing in patients with syncope.
| | 4. | Gain an appreciation of the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.
|
| | Day 2 | Diagnosis of Primary Headache Syndromes. - Upon completion of this session, the participant should be able to:
| 1. | Discuss the historical features of migraine, tension-type, and cluster headache.
| | 2. | Recognize which historical features best discriminate between migraine and tension-type headache.
| | 3. | List the triggers for migraine.
| | Treatment of Primary Headache Syndromes. - Upon completion of this session, the participant should be able to:
| | 1. | Appreciate the role of abortive therapy for migraine, tension-type, and cluster headache.
| | 2. | Recognize the range of options for pharmacologic preventive therapy for migraine, tension-type, and cluster headache.
| | 3. | Develop non-pharmacologic treatment strategies for migraine.
| | Peripheral Arterial Disease (PAD) – A Primary Care Perspective. - Upon completion of this session, the participant should be able to:
| | 1. | Describe the pathophysiology of arteriosclerosis, the most common cause of PAD.
| | 2. | Identify patients at increased risk for PAD.
| | 3. | Perform a focused history and physical examination to assess for PAD.
| | 4. | Have an appreciation of the role of ancillary testing.
| | 5. | Develop a plan for management of patients with PAD utilizing evidence-based guidelines for exercise, medications and revascularization.
| | Outpatient Anticoagulation Issues – What’s Important in Primary Care? - Upon completion of this session, the participant should be able to:
| | 1. | Manage outpatient warfarin using current guidelines.
| | 2. | Describe when and how to reverse the effects of warfarin.
| | 3. | Evaluate patients for hypercoagulable states and appreciate the implications.
| | 4. | Advise patients on the appropriate duration and intensity of anticoagulation in a variety of clinical scenarios.
|
| | Day 3 | Dyslipidemia. - Upon completion of this session, the participant should be able to:
| 1. | Apply recent changes to lipid management guidelines to their clinical practice.
| | 2. | Recognize secondary causes of dyslipidemia.
| | 3. | Describe treatment strategies for various dyslipidemic states.
| | Hepatitis B – An Update on Diagnosis and Management. - Upon completion of this session, the participant should be able to:
| | 1. | Review the natural history of a hepatitis B infection, including serologic markers and indications for treatment.
| | 2. | Describe options for treatment of hepatitis B, including the risks and benefits of new treatment modalities.
| | 3. | Describe common complications of chronic hepatitis B.
| | 4. | Review recommendations for hepatocellular carcinoma screening.
| | Preoperative Cardiac Evaluation. - Upon completion of this session, the participant should be able to:
| | 1. | Develop risk stratification for perioperative cardiac risk.
| | 2. | Demonstrate knowledge of preoperative cardiac risk guidelines and the revised cardiac risk index.
| | 3. | Properly use beta-blockers and statins for patients at risk for perioperative cardiac complications.
| | Preoperative Pulmonary Evaluation. - Upon completion of this session, the participant should be able to:
| | 1. | Identify patient and procedure-related risk factors for postoperative pulmonary complications.
| | 2. | Appreciate the limited role of preoperative spirometry.
| | 3. | Apply strategies to reduce the risk of postoperative pulmonary complications.
|
| | Day 4 | Prevention of Type 2 Diabetes. - Upon completion of this session, the participant should be able to:
| 1. | Describe the potential benefits of delaying and/or preventing the onset of type 2 diabetes.
| | 2. | Discuss the recommendations of professional organizations regarding diabetes prevention.
| | 3. | Counsel patients regarding potential benefits and risks of available therapeutic strategies for diabetes prevention.
| | Treatment of Hyperglycemia in Type 2 Diabetes. - Upon completion of this session, the participant should be able to:
| | 1. | Understand the pathogenesis and natural history of hyperglycemia in T2DM.
| | 2. | Describe current pharmacological treatment options.
| | 3. | Develop individualized regimens to optimize glycemic control.
| | Thyroid Nodules. - Upon completion of this session, the participant should be able to:
| | 1. | Describe the incidence of thyroid nodules in the primary care setting.
| | 2. | Discuss features from history and physical examination that increase the likelihood of malignancy.
| | 3. | Outline the best diagnostic approach to a thyroid nodule.
| | 4. | Review common cytologic findings from fine needle aspirate and their clinical significance.
| | Dizziness. - Upon completion of this session, the participant should be able to:
| | 1. | Differentiate between the most common causes of dizziness.
| | 2. | Distinguish between central and peripheral causes of vertigo.
| | 3. | Describe physical examination maneuvers used to diagnose and treat vertigo.
|
| | Day 5 | Evaluation of the Painful Knee in a Primary Care Setting. - Upon completion of this session, the participant should be able to:
| 1. | Recognize key historical features to help distinguish between common causes of knee pain in the primary care setting.
| | 2. | Demonstrate physical examination skills utilized in the diagnosis of common causes of knee pain.
| | 3. | Describe the treatment of common knee injuries in the primary care setting and determine which injuries require orthopedic consultation.
| | Evaluation and Treatment of the Painful Shoulder in the Primary Care Setting. - Upon completion of this session, the participant should be able to:
| | 1. | Review the anatomy of the shoulder in relation to common mechanisms of injury.
| | 2. | Describe and utilize key historical and physical examination skills needed to accurately diagnose common causes of shoulder pain in the primary care setting.
| | 3. | Describe the initial management of common shoulder injuries.
| | Common Thyroid Disorders. - Upon completion of this session, the participant should be able to:
| | 1. | Diagnose common causes of thyroid hyper-function and hypo-function.
| | 2. | Treat common thyroid function abnormalities.
| | 3. | Perform an appropriate evaluation of thyroid nodules.
| | Common Endocrine Disorders. - Upon completion of this session, the participant should be able to:
| | 1. | Recognize, evaluate and treat common adrenal, pituitary and gonadal abnormalities.
| | 2. | Evaluate disorders of calcium metabolism.
| | 3. | Counsel patients who are concerned they may have a "hormone problem”.
|
|
|